Apollomics Class A Stock Market Outlook
| APLM Stock | 19.79 0.59 3.07% |
About 62% of all Apollomics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Apollomics Class A suggests that some traders are interested. Apollomics' investing sentiment overview a quick insight into current market opportunities from investing in Apollomics Class A. Many technical investors use Apollomics Class A stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 62
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Apollomics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Apollomics Class A.
News SentimentBullish | Hype SentimentBullish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Apollomics Class A is 'Strong Hold'. The recommendation algorithm takes into account all of Apollomics' available fundamental, technical, and predictive indicators you will find on this site.
Apollomics | Build AI portfolio with Apollomics Stock |
Execute Apollomics Advice
The Apollomics recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Apollomics Class A. Macroaxis does not own or have any residual interests in Apollomics Class A or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Apollomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Apollomics Class A has a Risk Adjusted Performance of 0.0863, Jensen Alpha of 0.6764, Total Risk Alpha of 0.161, Sortino Ratio of 0.1037 and Treynor Ratio of 0.6025Our trade advice tool can cross-verify current analyst consensus on Apollomics Class A and to analyze the company potential to grow in the current economic cycle. To make sure Apollomics is not overpriced, please confirm all Apollomics Class A fundamentals, including its cash flow from operations, and the relationship between the gross profit and beta . Given that Apollomics Class A has a number of shares shorted of 17.61 K, we suggest you to validate Apollomics Class A market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Apollomics Trading Alerts and Improvement Suggestions
| Apollomics Class A had very high historical volatility over the last 90 days | |
| Apollomics Class A has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 198 K. Net Loss for the year was (53.86 M) with profit before overhead, payroll, taxes, and interest of 198 K. | |
| Apollomics generates negative cash flow from operations | |
| Apollomics Class A has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Apollomics Upgraded at Wall Street Zen |
Apollomics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apollomics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apollomics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Apollomics Returns Distribution Density
The distribution of Apollomics' historical returns is an attempt to chart the uncertainty of Apollomics' future price movements. The chart of the probability distribution of Apollomics daily returns describes the distribution of returns around its average expected value. We use Apollomics Class A price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Apollomics returns is essential to provide solid investment analysis for Apollomics.
| Mean Return | 0.76 | Value At Risk | -11.4 | Potential Upside | 17.08 | Standard Deviation | 7.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Apollomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Apollomics Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | (83.9M) | (14.1M) | (619K) | (22.3M) | (20.1M) | (19.1M) | |
| Free Cash Flow | (43.4M) | (43.2M) | (43.2M) | (28.8M) | (25.9M) | (27.2M) | |
| Depreciation | 681K | 775K | 669K | 361K | 324.9K | 308.7K | |
| Other Non Cash Items | 43.1M | 190.0M | 117.0M | 12.2M | 14.1M | 13.4M | |
| Capital Expenditures | 50K | 367K | 6K | 24K | 21.6K | 20.5K | |
| Net Income | (94.8M) | (240.8M) | (172.6M) | (53.9M) | (48.5M) | (50.9M) | |
| End Period Cash Flow | 46.7M | 32.7M | 32.1M | 9.8M | 8.8M | 8.3M | |
| Investments | (39.0M) | 29.1M | 21.4M | 6.0M | 6.9M | 4.4M |
Apollomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Apollomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Apollomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Apollomics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.68 | |
β | Beta against Dow Jones | 1.25 | |
σ | Overall volatility | 6.93 | |
Ir | Information ratio | 0.09 |
Apollomics Volatility Alert
Apollomics Class A is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Apollomics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Apollomics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Apollomics Fundamentals Vs Peers
Comparing Apollomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Apollomics' direct or indirect competition across all of the common fundamentals between Apollomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Apollomics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Apollomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Apollomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Apollomics to competition |
| Fundamentals | Apollomics | Peer Average |
| Return On Equity | -2.34 | -0.31 |
| Return On Asset | -0.75 | -0.14 |
| Operating Margin | 10.07 % | (5.51) % |
| Current Valuation | 41.5 M | 16.62 B |
| Shares Outstanding | 2.14 M | 571.82 M |
| Shares Owned By Institutions | 0.67 % | 39.21 % |
| Number Of Shares Shorted | 17.61 K | 4.71 M |
| Price To Book | 8.12 X | 9.51 X |
| Price To Sales | 5.94 X | 11.42 X |
| Revenue | 198 K | 9.43 B |
| Gross Profit | 198 K | 27.38 B |
| EBITDA | (41.05 M) | 3.9 B |
| Net Income | (53.86 M) | 570.98 M |
| Total Debt | 966 K | 5.32 B |
| Book Value Per Share | 4.41 X | 1.93 K |
| Cash Flow From Operations | (28.74 M) | 971.22 M |
| Short Ratio | 0.28 X | 4.00 X |
| Earnings Per Share | (52.80) X | 3.12 X |
| Target Price | 2.0 | |
| Number Of Employees | 13 | 18.84 K |
| Beta | 1.81 | -0.15 |
| Market Capitalization | 44.92 M | 19.03 B |
| Total Asset | 13.1 M | 29.47 B |
| Retained Earnings | (700.82 M) | 9.33 B |
| Working Capital | 2.87 M | 1.48 B |
| Net Asset | 13.1 M |
Note: Conversion by Yungfong Song of 2482500 shares of Apollomics [view details]
Apollomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Apollomics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Apollomics Target Price Consensus
Apollomics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Apollomics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Buy |
Most Apollomics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Apollomics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Apollomics Class A, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationApollomics Target Price Projection
Apollomics' current and average target prices are 19.79 and 2.00, respectively. The current price of Apollomics is the price at which Apollomics Class A is currently trading. On the other hand, Apollomics' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Apollomics Market Quote on 14th of February 2026
Target Price
Analyst Consensus On Apollomics Target Price
Apollomics Analyst Ratings
Apollomics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Apollomics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Apollomics' financials, market performance, and future outlook by experienced professionals. Apollomics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About Apollomics Buy or Sell Advice
When is the right time to buy or sell Apollomics Class A? Buying financial instruments such as Apollomics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Apollomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Penny Thematic Idea Now
Penny
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Apollomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Biotechnology sector continue expanding? Could Apollomics diversify its offerings? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apollomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (52.80) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Apollomics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apollomics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Apollomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.